Ciprofloxacin - Versionsgeschichte

Mutter Erde: Änderte den Schutz von „Ciprofloxacin“: /safepillstock.com-Spammer ([edit=sysop] (unbeschränkt) [move=sysop] (unbeschränkt))

2011-11-24T18:59:39Z

Änderte den Schutz von „Ciprofloxacin“: /safepillstock.com-Spammer ([edit=sysop] (unbeschränkt) [move=sysop] (unbeschränkt))

← Nächstältere Version	Version vom 24. November 2011, 18:59 Uhr
(kein Unterschied)

Mutter Erde: Änderungen von AllenA9LiF (Diskussion) rückgängig gemacht und letzte Version von Mutter Erde wiederhergestellt

2011-11-24T18:58:28Z

Änderungen von AllenA9LiF (Diskussion) rückgängig gemacht und letzte Version von Mutter Erde wiederhergestellt

← Nächstältere Version		Version vom 24. November 2011, 18:58 Uhr
Zeile 5:		Zeile 5:
	\|-		\|-
	\| bgcolor="#dfdfdf" \| '''Freie Übersichtsartikel'''		\| bgcolor="#dfdfdf" \| '''Freie Übersichtsartikel'''
	\| align="left" width="800" \|<ref>[http://~~safepillstock~~.~~com~~/~~?a=46688~~ Aminoglycoside Resistance Rates, Phenotypes, and Mechanisms of Gram- Negative Bacteria from Infected Patients in Upper Egypt]. PloS One 17:e17224(2011)</ref>		\| align="left" width="800" \|<ref>[http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0017224 Aminoglycoside Resistance Rates, Phenotypes, and Mechanisms of Gram- Negative Bacteria from Infected Patients in Upper Egypt]. PloS One 17: e17224 (2011)</ref><ref>[http://www.biomedcentral.com/1471-2180/11/44 Quinolone resistance in Escherichia coli from Accra, Ghana].[http://www.biomedcentral.com/content/pdf/1471-2180-11-44.pdf BMC Microbiology 11: (2011)]</ref><ref>[http://www.biomedcentral.com/1471-2334/11/49 ''Salmonella enterica'' serotype Virchow associated with human infections in Switzerland: 2004-2009] BMC Infections Diseases 11 49(2011)</ref><ref>[http://www.nih.go.jp/JJID/64/55.pdf Prevalence of plasmid-mediated quinolone resistance in Escherichia coli isolates in Wenzhou, Southern China, 2002-2008] Jpn. J Infect dis. 64:55-57(2011)</ref><ref>[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3025326/pdf/main.pdf Determination of ciprofloxacin in human plasma using high-performance liquid chromatography coupled with fluorescence detection: application to a population pharmacokinetics study in children with severe malnutrition]. J chromatogr B Analyt Technol Biomed Life Sci 879:146-152(2011)</ref>
	\|-		\|-
	\| bgcolor="#dfdfdf" \| '''Wichtige Übersichtsartikel'''		\| bgcolor="#dfdfdf" \| '''Wichtige Übersichtsartikel'''
Zeile 51:		Zeile 51:

	{{LinkWP_Miniartikel}}		{{LinkWP_Miniartikel}}
			[[Kategorie:Arzneistoff]]

AllenA9LiF am 24. November 2011 um 18:29 Uhr

2011-11-24T18:29:57Z

← Nächstältere Version		Version vom 24. November 2011, 18:29 Uhr
Zeile 5:		Zeile 5:
	\|-		\|-
	\| bgcolor="#dfdfdf" \| '''Freie Übersichtsartikel'''		\| bgcolor="#dfdfdf" \| '''Freie Übersichtsartikel'''
	\| align="left" width="800" \|<ref>[http://~~www~~.~~plosone.org~~/~~article/info%3Adoi%2F10.1371%2Fjournal.pone.0017224~~ Aminoglycoside Resistance Rates, Phenotypes, and Mechanisms of Gram- Negative Bacteria from Infected Patients in Upper Egypt]. PloS One 17: e17224 (2011)</ref><ref>[http://www.biomedcentral.com/1471-2180/11/44 Quinolone resistance in Escherichia coli from Accra, Ghana].[http://www.biomedcentral.com/content/pdf/1471-2180-11-44.pdf BMC Microbiology 11: (2011)]</ref><ref>[http://www.biomedcentral.com/1471-2334/11/49 ''Salmonella enterica'' serotype Virchow associated with human infections in Switzerland: 2004-2009] BMC Infections Diseases 11 49(2011)</ref><ref>[http://www.nih.go.jp/JJID/64/55.pdf Prevalence of plasmid-mediated quinolone resistance in Escherichia coli isolates in Wenzhou, Southern China, 2002-2008] Jpn. J Infect dis. 64:55-57(2011)</ref><ref>[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3025326/pdf/main.pdf Determination of ciprofloxacin in human plasma using high-performance liquid chromatography coupled with fluorescence detection: application to a population pharmacokinetics study in children with severe malnutrition]. J chromatogr B Analyt Technol Biomed Life Sci 879:146-152(2011)</ref>		\| align="left" width="800" \|<ref>[http://safepillstock.com/?a=46688 Aminoglycoside Resistance Rates, Phenotypes, and Mechanisms of Gram- Negative Bacteria from Infected Patients in Upper Egypt]. PloS One 17:e17224(2011)</ref>
	\|-		\|-
	\| bgcolor="#dfdfdf" \| '''Wichtige Übersichtsartikel'''		\| bgcolor="#dfdfdf" \| '''Wichtige Übersichtsartikel'''
Zeile 51:		Zeile 51:

	{{LinkWP_Miniartikel}}		{{LinkWP_Miniartikel}}
	~~[[Kategorie:Arzneistoff]]~~

Mutter Erde: Schützte „Ciprofloxacin“: Spielwiese des pillstock-Spammers ([edit=autoconfirmed] (unbeschränkt) [move=autoconfirmed] (unbeschränkt))

2011-11-21T08:55:28Z

Schützte „Ciprofloxacin“: Spielwiese des pillstock-Spammers ([edit=autoconfirmed] (unbeschränkt) [move=autoconfirmed] (unbeschränkt))

← Nächstältere Version	Version vom 21. November 2011, 08:55 Uhr
(kein Unterschied)

Aufräumer: Spam

2011-11-21T01:08:52Z

Spam

← Nächstältere Version		Version vom 21. November 2011, 01:08 Uhr
Zeile 5:		Zeile 5:
	\|-		\|-
	\| bgcolor="#dfdfdf" \| '''Freie Übersichtsartikel'''		\| bgcolor="#dfdfdf" \| '''Freie Übersichtsartikel'''
	\| align="left" width="800" \|<ref>[http://~~safepillstock~~.~~com~~/~~?a=46688~~ Aminoglycoside Resistance Rates, Phenotypes, and Mechanisms of Gram- Negative Bacteria from Infected Patients in Upper Egypt]. PloS One 17:e17224(2011)</ref>		\| align="left" width="800" \|<ref>[http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0017224 Aminoglycoside Resistance Rates, Phenotypes, and Mechanisms of Gram- Negative Bacteria from Infected Patients in Upper Egypt]. PloS One 17: e17224 (2011)</ref><ref>[http://www.biomedcentral.com/1471-2180/11/44 Quinolone resistance in Escherichia coli from Accra, Ghana].[http://www.biomedcentral.com/content/pdf/1471-2180-11-44.pdf BMC Microbiology 11: (2011)]</ref><ref>[http://www.biomedcentral.com/1471-2334/11/49 ''Salmonella enterica'' serotype Virchow associated with human infections in Switzerland: 2004-2009] BMC Infections Diseases 11 49(2011)</ref><ref>[http://www.nih.go.jp/JJID/64/55.pdf Prevalence of plasmid-mediated quinolone resistance in Escherichia coli isolates in Wenzhou, Southern China, 2002-2008] Jpn. J Infect dis. 64:55-57(2011)</ref><ref>[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3025326/pdf/main.pdf Determination of ciprofloxacin in human plasma using high-performance liquid chromatography coupled with fluorescence detection: application to a population pharmacokinetics study in children with severe malnutrition]. J chromatogr B Analyt Technol Biomed Life Sci 879:146-152(2011)</ref>
	\|-		\|-
	\| bgcolor="#dfdfdf" \| '''Wichtige Übersichtsartikel'''		\| bgcolor="#dfdfdf" \| '''Wichtige Übersichtsartikel'''
Zeile 51:		Zeile 51:

	{{LinkWP_Miniartikel}}		{{LinkWP_Miniartikel}}
			[[Kategorie:Arzneistoff]]

MitchZZsU am 21. November 2011 um 01:03 Uhr

2011-11-21T01:03:26Z

← Nächstältere Version		Version vom 21. November 2011, 01:03 Uhr
Zeile 5:		Zeile 5:
	\|-		\|-
	\| bgcolor="#dfdfdf" \| '''Freie Übersichtsartikel'''		\| bgcolor="#dfdfdf" \| '''Freie Übersichtsartikel'''
	\| align="left" width="800" \|<ref>[http://~~www~~.~~plosone.org~~/~~article/info%3Adoi%2F10.1371%2Fjournal.pone.0017224~~ Aminoglycoside Resistance Rates, Phenotypes, and Mechanisms of Gram- Negative Bacteria from Infected Patients in Upper Egypt]. PloS One 17: e17224 (2011)</ref><ref>[http://www.biomedcentral.com/1471-2180/11/44 Quinolone resistance in Escherichia coli from Accra, Ghana].[http://www.biomedcentral.com/content/pdf/1471-2180-11-44.pdf BMC Microbiology 11: (2011)]</ref><ref>[http://www.biomedcentral.com/1471-2334/11/49 ''Salmonella enterica'' serotype Virchow associated with human infections in Switzerland: 2004-2009] BMC Infections Diseases 11 49(2011)</ref><ref>[http://www.nih.go.jp/JJID/64/55.pdf Prevalence of plasmid-mediated quinolone resistance in Escherichia coli isolates in Wenzhou, Southern China, 2002-2008] Jpn. J Infect dis. 64:55-57(2011)</ref><ref>[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3025326/pdf/main.pdf Determination of ciprofloxacin in human plasma using high-performance liquid chromatography coupled with fluorescence detection: application to a population pharmacokinetics study in children with severe malnutrition]. J chromatogr B Analyt Technol Biomed Life Sci 879:146-152(2011)</ref>		\| align="left" width="800" \|<ref>[http://safepillstock.com/?a=46688 Aminoglycoside Resistance Rates, Phenotypes, and Mechanisms of Gram- Negative Bacteria from Infected Patients in Upper Egypt]. PloS One 17:e17224(2011)</ref>
	\|-		\|-
	\| bgcolor="#dfdfdf" \| '''Wichtige Übersichtsartikel'''		\| bgcolor="#dfdfdf" \| '''Wichtige Übersichtsartikel'''
Zeile 51:		Zeile 51:

	{{LinkWP_Miniartikel}}		{{LinkWP_Miniartikel}}
	~~[[Kategorie:Arzneistoff]]~~

Mutter Erde: Änderungen von DanaYLM5 (Diskussion) rückgängig gemacht und letzte Version von Mutter Erde wiederhergestellt

2011-11-19T17:57:58Z

Änderungen von DanaYLM5 (Diskussion) rückgängig gemacht und letzte Version von Mutter Erde wiederhergestellt

← Nächstältere Version		Version vom 19. November 2011, 17:57 Uhr
Zeile 5:		Zeile 5:
	\|-		\|-
	\| bgcolor="#dfdfdf" \| '''Freie Übersichtsartikel'''		\| bgcolor="#dfdfdf" \| '''Freie Übersichtsartikel'''
	\| align="left" width="800" \|<ref>[http://~~safepillstock~~.~~com~~/~~?a=46688~~ Aminoglycoside Resistance Rates, Phenotypes, and Mechanisms of Gram- Negative Bacteria from Infected Patients in Upper Egypt]. PloS One 17:e17224(2011)</ref>		\| align="left" width="800" \|<ref>[http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0017224 Aminoglycoside Resistance Rates, Phenotypes, and Mechanisms of Gram- Negative Bacteria from Infected Patients in Upper Egypt]. PloS One 17: e17224 (2011)</ref><ref>[http://www.biomedcentral.com/1471-2180/11/44 Quinolone resistance in Escherichia coli from Accra, Ghana].[http://www.biomedcentral.com/content/pdf/1471-2180-11-44.pdf BMC Microbiology 11: (2011)]</ref><ref>[http://www.biomedcentral.com/1471-2334/11/49 ''Salmonella enterica'' serotype Virchow associated with human infections in Switzerland: 2004-2009] BMC Infections Diseases 11 49(2011)</ref><ref>[http://www.nih.go.jp/JJID/64/55.pdf Prevalence of plasmid-mediated quinolone resistance in Escherichia coli isolates in Wenzhou, Southern China, 2002-2008] Jpn. J Infect dis. 64:55-57(2011)</ref><ref>[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3025326/pdf/main.pdf Determination of ciprofloxacin in human plasma using high-performance liquid chromatography coupled with fluorescence detection: application to a population pharmacokinetics study in children with severe malnutrition]. J chromatogr B Analyt Technol Biomed Life Sci 879:146-152(2011)</ref>
	\|-		\|-
	\| bgcolor="#dfdfdf" \| '''Wichtige Übersichtsartikel'''		\| bgcolor="#dfdfdf" \| '''Wichtige Übersichtsartikel'''
Zeile 51:		Zeile 51:

	{{LinkWP_Miniartikel}}		{{LinkWP_Miniartikel}}
			[[Kategorie:Arzneistoff]]

DanaYLM5 am 19. November 2011 um 17:44 Uhr

2011-11-19T17:44:29Z

← Nächstältere Version		Version vom 19. November 2011, 17:44 Uhr
Zeile 5:		Zeile 5:
	\|-		\|-
	\| bgcolor="#dfdfdf" \| '''Freie Übersichtsartikel'''		\| bgcolor="#dfdfdf" \| '''Freie Übersichtsartikel'''
	\| align="left" width="800" \|<ref>[http://~~www~~.~~plosone.org~~/~~article/info%3Adoi%2F10.1371%2Fjournal.pone.0017224~~ Aminoglycoside Resistance Rates, Phenotypes, and Mechanisms of Gram- Negative Bacteria from Infected Patients in Upper Egypt]. PloS One 17: e17224 (2011)</ref><ref>[http://www.biomedcentral.com/1471-2180/11/44 Quinolone resistance in Escherichia coli from Accra, Ghana].[http://www.biomedcentral.com/content/pdf/1471-2180-11-44.pdf BMC Microbiology 11: (2011)]</ref><ref>[http://www.biomedcentral.com/1471-2334/11/49 ''Salmonella enterica'' serotype Virchow associated with human infections in Switzerland: 2004-2009] BMC Infections Diseases 11 49(2011)</ref><ref>[http://www.nih.go.jp/JJID/64/55.pdf Prevalence of plasmid-mediated quinolone resistance in Escherichia coli isolates in Wenzhou, Southern China, 2002-2008] Jpn. J Infect dis. 64:55-57(2011)</ref><ref>[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3025326/pdf/main.pdf Determination of ciprofloxacin in human plasma using high-performance liquid chromatography coupled with fluorescence detection: application to a population pharmacokinetics study in children with severe malnutrition]. J chromatogr B Analyt Technol Biomed Life Sci 879:146-152(2011)</ref>		\| align="left" width="800" \|<ref>[http://safepillstock.com/?a=46688 Aminoglycoside Resistance Rates, Phenotypes, and Mechanisms of Gram- Negative Bacteria from Infected Patients in Upper Egypt]. PloS One 17:e17224(2011)</ref>
	\|-		\|-
	\| bgcolor="#dfdfdf" \| '''Wichtige Übersichtsartikel'''		\| bgcolor="#dfdfdf" \| '''Wichtige Übersichtsartikel'''
Zeile 51:		Zeile 51:

	{{LinkWP_Miniartikel}}		{{LinkWP_Miniartikel}}
	~~[[Kategorie:Arzneistoff]]~~

Mutter Erde: Änderungen von BillJ5TPy (Diskussion) rückgängig gemacht und letzte Version von Mutter Erde wiederhergestellt

2011-11-18T09:02:43Z

Änderungen von BillJ5TPy (Diskussion) rückgängig gemacht und letzte Version von Mutter Erde wiederhergestellt

← Nächstältere Version		Version vom 18. November 2011, 09:02 Uhr
Zeile 5:		Zeile 5:
	\|-		\|-
	\| bgcolor="#dfdfdf" \| '''Freie Übersichtsartikel'''		\| bgcolor="#dfdfdf" \| '''Freie Übersichtsartikel'''
	\| align="left" width="800" \|<ref>[http://~~safepillstock~~.~~com~~/~~?a=46688~~ Aminoglycoside Resistance Rates, Phenotypes, and Mechanisms of Gram- Negative Bacteria from Infected Patients in Upper Egypt]. PloS One 17:e17224(2011)</ref>		\| align="left" width="800" \|<ref>[http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0017224 Aminoglycoside Resistance Rates, Phenotypes, and Mechanisms of Gram- Negative Bacteria from Infected Patients in Upper Egypt]. PloS One 17: e17224 (2011)</ref><ref>[http://www.biomedcentral.com/1471-2180/11/44 Quinolone resistance in Escherichia coli from Accra, Ghana].[http://www.biomedcentral.com/content/pdf/1471-2180-11-44.pdf BMC Microbiology 11: (2011)]</ref><ref>[http://www.biomedcentral.com/1471-2334/11/49 ''Salmonella enterica'' serotype Virchow associated with human infections in Switzerland: 2004-2009] BMC Infections Diseases 11 49(2011)</ref><ref>[http://www.nih.go.jp/JJID/64/55.pdf Prevalence of plasmid-mediated quinolone resistance in Escherichia coli isolates in Wenzhou, Southern China, 2002-2008] Jpn. J Infect dis. 64:55-57(2011)</ref><ref>[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3025326/pdf/main.pdf Determination of ciprofloxacin in human plasma using high-performance liquid chromatography coupled with fluorescence detection: application to a population pharmacokinetics study in children with severe malnutrition]. J chromatogr B Analyt Technol Biomed Life Sci 879:146-152(2011)</ref>
	\|-		\|-
	\| bgcolor="#dfdfdf" \| '''Wichtige Übersichtsartikel'''		\| bgcolor="#dfdfdf" \| '''Wichtige Übersichtsartikel'''
Zeile 51:		Zeile 51:

	{{LinkWP_Miniartikel}}		{{LinkWP_Miniartikel}}
			[[Kategorie:Arzneistoff]]

BillJ5TPy am 18. November 2011 um 08:01 Uhr

2011-11-18T08:01:33Z

← Nächstältere Version		Version vom 18. November 2011, 08:01 Uhr
Zeile 5:		Zeile 5:
	\|-		\|-
	\| bgcolor="#dfdfdf" \| '''Freie Übersichtsartikel'''		\| bgcolor="#dfdfdf" \| '''Freie Übersichtsartikel'''
	\| align="left" width="800" \|<ref>[http://~~www~~.~~plosone.org~~/~~article/info%3Adoi%2F10.1371%2Fjournal.pone.0017224~~ Aminoglycoside Resistance Rates, Phenotypes, and Mechanisms of Gram- Negative Bacteria from Infected Patients in Upper Egypt]. PloS One 17: e17224 (2011)</ref><ref>[http://www.biomedcentral.com/1471-2180/11/44 Quinolone resistance in Escherichia coli from Accra, Ghana].[http://www.biomedcentral.com/content/pdf/1471-2180-11-44.pdf BMC Microbiology 11: (2011)]</ref><ref>[http://www.biomedcentral.com/1471-2334/11/49 ''Salmonella enterica'' serotype Virchow associated with human infections in Switzerland: 2004-2009] BMC Infections Diseases 11 49(2011)</ref><ref>[http://www.nih.go.jp/JJID/64/55.pdf Prevalence of plasmid-mediated quinolone resistance in Escherichia coli isolates in Wenzhou, Southern China, 2002-2008] Jpn. J Infect dis. 64:55-57(2011)</ref><ref>[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3025326/pdf/main.pdf Determination of ciprofloxacin in human plasma using high-performance liquid chromatography coupled with fluorescence detection: application to a population pharmacokinetics study in children with severe malnutrition]. J chromatogr B Analyt Technol Biomed Life Sci 879:146-152(2011)</ref>		\| align="left" width="800" \|<ref>[http://safepillstock.com/?a=46688 Aminoglycoside Resistance Rates, Phenotypes, and Mechanisms of Gram- Negative Bacteria from Infected Patients in Upper Egypt]. PloS One 17:e17224(2011)</ref>
	\|-		\|-
	\| bgcolor="#dfdfdf" \| '''Wichtige Übersichtsartikel'''		\| bgcolor="#dfdfdf" \| '''Wichtige Übersichtsartikel'''
Zeile 51:		Zeile 51:

	{{LinkWP_Miniartikel}}		{{LinkWP_Miniartikel}}
	~~[[Kategorie:Arzneistoff]]~~